Stay updated on Nivolumab in Type B3 Thymoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Type B3 Thymoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added the NIH grant/contract identifier '2015 ( U.S. NIH Grant/Contract )' to the study's identifiers. Updated the page revision to v3.6.6, replacing v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T20:02:03.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page shows a new revision label, v3.6.5, replacing the previous v3.6.4. This reflects a minor update or re-release of the page content.
    Difference
    0.0%
    Check dated 2026-08-08T20:02:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision label on the page was updated to v3.6.4, replacing the previous v3.6.3 as part of a small software update.
    Difference
    0.0%
    Check dated 2026-07-25T12:37:10.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.6.3 appeared on the page, indicating a newer version of the study entry.
    Difference
    0.0%
    Check dated 2026-07-03T23:00:51.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This appears to reflect minor fixes or adjustments rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-06-27T01:20:19.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    The page now includes a recruitment status note indicating no participant recruitment, and introduces new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while updating the revision to v3.6.0 and adjusting the 'Intervention/Treatment' heading formatting.
    Difference
    0.4%
    Check dated 2026-06-12T16:48:43.000Z thumbnail image

Stay in the know with updates to Nivolumab in Type B3 Thymoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Type B3 Thymoma Clinical Trial page.